chrisvoncsefalvay/vaers-outcomes huggingface dataset:
chest pain / Every now and then throughout the day, I have pain about my heart pocket / happens at least once a day; could also be Anxiety; muscle ache more significant starting the day after the second vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of CHEST PAIN (chest pain / Every now and then throughout the day, I have pain about my heart pocket / happens at least once a day), ANXIETY (could also be Anxiety) and MYALGIA (muscle ache more significant starting the day after the second vaccine) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CELECOXIB (CELEBREX) for Arthritis, AMLODIPINE, HYDROCHLOROTHIAZIDE and IRBESARTAN for Blood pressure high.    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced MYALGIA (muscle ache more significant starting the day after the second vaccine). On an unknown date, the patient experienced CHEST PAIN (chest pain / Every now and then throughout the day, I have pain about my heart pocket / happens at least once a day) and ANXIETY (could also be Anxiety). The patient was treated with MELOXICAM for Muscle ache, at an unspecified dose and frequency. At the time of the report, CHEST PAIN (chest pain / Every now and then throughout the day, I have pain about my heart pocket / happens at least once a day), ANXIETY (could also be Anxiety) and MYALGIA (muscle ache more significant starting the day after the second vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Vaccinated with 1st dose of Pfizer COVID vaccine 12/18/2020.  On 12/22/2020 the patient had cough, nasal congestion, and pharyngitis.   +PCR
difficulty breathing; Uncontrolled shaking; This is a spontaneous report from a non-contactable consumer or non-healthcare professional (patient).   A 49-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: unknown, Expiration date: not reported), via an unspecified route of administration on an unspecified date in Mar2021 as a dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. No covid prior vaccination and no covid tested post vaccination. On an unspecified date in 2021, the patient experienced uncontrolled shaking and difficulty breathing. The AE resulted in emergency room/department or urgent care. The patient was hospitalized for the events. The outcome of the events was unknown.  No follow up attempts are possible. Information about lot/batch number cannot be requested. No further information is expected.
sore right injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore right injection site arm) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LIOTHYRONINE SODIUM (T3) from an unknown date to 01-Mar-2021 for an unknown indication.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Dec-2020,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (sore right injection site arm) (seriousness criterion medically significant). At the time of the report, VACCINATION SITE PAIN (sore right injection site arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient had a sore right injection site arm which felt better in a few days.  No treatment medication was reported.  Company comment: This case concerns a 61-year-old mal subject who experienced the expected event of  VACCINATION SITE PAIN. The event occurred the same date after the first dose of Spikevax and it had resolved. The event is consistent with the current understanding of the mechanism of action of the study medication. The benefit-risk relationship of spikevax is not affected by this report.   This case was linked to MOD-2021-319204 (Patient Link).; Sender's Comments: This case concerns a 61-year-old mal subject who experienced the expected event of  VACCINATION SITE PAIN. The event occurred the same date after the first dose of Spikevax and it had resolved. The event is consistent with the current understanding of the mechanism of action of the study medication. The benefit-risk relationship of spikevax is not affected by this report.
Gave monovalent moderna as a booster after deauthorization.  Family was advised to come back in 2 months for bivalent booster.
A few hours subsequent to receiving the first doe of Engerix B (10/21/1999) the pt experienced slight nausea, and numbness/tingling in her pinky finger. The outcome of the condition was resolved. The Pt received her second dose of Engerix B on 11/19/1999 and one day post vax the pt experienced numbness in pinky finger to thumb, lips and side of nose. The duration was five minutes. No treatment was given. The most recent information received reports the condition of the pt is resolved.
Information has been received from a 39 year old female patient who was allergic to vitamin. No other relevant medical history or concurrent conditions were reported. On 17-APR-2015 the patient was vaccinated with (Merck) VARIVAX (lot#, expiration date, dose and route not reported). There was not concomitant medication. The patient reported after receiving the vaccination she found out she was pregnant. The patient's Last Menstrual Period (LMP) was 19-MAY-2015 and Estimated Delivery Date (EDD) was 23-FEB-2016. She sought medical attention by visiting the physician's office. Blood work was performed on an unknown date (result not provided). No treatment was given for the event. No adverse event was reported. Additional information has been requested.
Patient presented to the hospital on 12/12/21 with headaches and visual disturbance. She noticed "blackness" of her peripheral vision in her right eye. Imaging showed evolving left occipital infarct and she was seen by stroke neurology who recommended dual antiplatelet therapy and high-dose statin. Echo with bubble study showed PFO. She was treated with Solu-Medrol, Zosyn, and BiPAP temporarily. She was treated with Zosyn on 12/12-12/13, and then ceftriaxone until 12/15/21. The decision was made to discharge her without further antibiotics or steroids since she is breathing comfortably on room air and does not feel short of breath. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
At approx 5:30pm the day of the vaccination, I began feeling dizzy, almost as though I was intoxicated. The dizziness got progressively more intense and continued throughout the night, as well as for the next 3 days. I took 1200 mg of vitamin C which seemed to help, but the dizziness still lingures to this day. It comes and goes and occurs daily. I scheduled a telehealth appt with my GP for the following wednesday 4/28, and informed him. He said he hadnt heard of any reports of dizziness, and thought it's possible a second dose could make the symptoms worse, but he couldnt say for sure.  Today, 5/2, my menstrual cycle started and very heavily, but it isnt due for another 2 weeks. I have read about this happening with many other women reporting the same, their cycles starting shortly after vaccination, so it does have me on the alert and a bit concerned.
Per documentation: "numbness/tingling medial left hand/wrist and decreased grip strength left hand. Pt also reported some LAD left axilla." Narrative:
On 04/01/05, 2 days after receiving hepatitis B vaccine (Engerix B), she developed mild pruritic erythematous rash, involving the trunk, extremities and sparing face. This patient reported mild URI symptoms which started 1 day prior to vaccination; felt well, no fever on date of vaccination. Lesions have continued to appear through 04/03/05. No fever, no urticaria, no medication. Has not recovered yet.
severe dysplasia due to HPV; severe dysplasia due to HPV; She reports her daughter received three doses of GARDASIL 9 between 2014-2015 and despite being fully vaccinated, still developed severe dysplasia due to HPV; Product Lot number issue; This spontaneous report was received from a clinical director who is a patent's mother and refers to a 22-year-old (reported also as currently 23-year-old) female patient.  The patient's pertinent medical history, drug reactions or allergies and concurrent conditions were not reported. The patient's concomitant medications included birth control pills.  On 11-SEP-2014, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered intramuscularly for prophylaxis (dose, strength, lot #, and expiry date were not provided) or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection, lot #K003520, expiration date: 20-NOV-2016, administered intramuscularly for prophylaxis (dose, strength was not provided) (product lot number issue).  On 11-NOV-2014, the patient was vaccinated with additional dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), lot #K009482, expiry date: 06-MAR-2017.  On 11-MAR-2015, the patient was vaccinated with additional dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), lot #K008931, expiry date: 04-MAR-2017.  Reporter reported hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) with lot #K003520, #K009482 and #K008931 which were not valid for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). However, lot #K003520, #K009482 and #K008931 are valid for quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL).  On an unknown date in July 2022, the patient experienced human papillomavirus (HPV) infection despite being fully vaccinated with three doses of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (vaccination failure). On an unknown date in July 2022, the patient experienced severe dysplasia due to the HPV, and was treated for it.  On an unknown date in July 2022, the patient was first diagnosed with dysplasia via routine pap smear which showed abnormal.  On an unknown date in 2022, the patient subsequently had a biopsy to confirm the dysplasia diagnosis and a cone procedure to surgically remove the tissue with the HPV. Biopsy showed severe dysplasia.  At the time of reporting, the patient was recovering from the events of dysplasia and HPV infection and the reporter states that she does not have any further procedures planned for treatment. The outcome of vaccination failure was not reported.  The causal relationship between the events and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was unknown. The causal relationship between the events and quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) was unknown.
headache, nausea, body aches, chills, muscle pain, swollen lymph nodes, fever, fatigue, soreness
My immediate reaction was blurred vision, then pain down my right arm. Next my pulse rapidly increased, and my breathing was labored.  My finger tips of both hands felt almost numb, and my hands turned red.  I became very lethargic, and both legs became very weak.   I remained in the facility for 1.5 hours under the care of a RN.  I went home and it took approximately 4 hours for me to recover. 3 days later I woke up with a metallic taste in my mouth that lasted 2 days.
9 days after my shot my arm swelled in the shot area. It felt very hot. It broke out in a rash and was very itchy. Today 3/26/ it is still slightly itchy and the swelling is down and rash is gone.
This spontaneous report as received from a healthcare worker refers to a female patient of unknown age. On 05-FEB-2014 the patient was vaccinated with the first dose of GARDASIL (lot number reported as J008423, expiry date 21-JAN-2016, intramuscularly, 0.5 ml). On 24-JUN-2014, patient was confirmed to be pregnant by urine test. Her last menstrual period was 23-MAR-2014 and estimated date of delivery is 28-DEC-2014. The pregnancy outcome was pending. No treatment was provided. Patient sought medical attention. There was no significant disability, the experienced was not life threatening and there was no hospitalization. A product quality complaint was also not involved. Outcome of the vaccine exposure during pregnancy was unknown. Additional information has been requested.
Arm/shoulder pain, burning from wrist to shoulder - Patient called today 10/27/16 to report this reaction.
I've suffered repeated herpetic viral infections beginning about a month after the second dosage of the Moderna COVID-19 vaccine.  Herpetic infections have recurred in my eye and my throat.  I've never experienced recurring infections or herpetic infections of the eye or throat before.
1/27/21 0200 measured temp 1027 behind ear, repeat 102.2. 1/27/21 0200 measured temp 102.7 behind ear, forehead 102.2. Temp came down on own without intervention.
Wednesday 11/16- sore arm, swollen, hot to the touch, fever >103, trouble breathing, chest pain, dizziness on thursday 11/17 took benadryl for reaction with no improvement. saw urgent care on friday 11/18 and was prescribed prednisone
We both feel like we have the flu; I have muscle twitching; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 4th February 2020, the patient received the 2nd dose of Shingrix. In February 2020, less than a week after receiving Shingrix, the patient experienced influenza-like symptoms and muscle twitching. On an unknown date, the outcome of the influenza-like symptoms and muscle twitching were unknown.   It was unknown if the reporter considered the influenza-like symptoms and muscle twitching to be related to Shingrix.  Additional details were provided as follows: The patient felt like she had the flu and muscle twitching after receiving Shingrix. This case has been linked with case US2020AMR020739,reported by same reporter
Thyroid eye disease (TED); This is a literature report for the following literature source(s):   A 53-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Non smoker" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: ENDOCRINE OPHTHALMOPATHY (medically significant), 24 hrs after the suspect product(s) administration, outcome "recovering", described as "Thyroid eye disease (TED)". The patient underwent the following laboratory tests and procedures: CAS: 2/7; Thyroid stimulating immunoglobulin: 3.21 IU/l. Therapeutic measures were taken as a result of endocrine ophthalmopathy.; Sender's Comments: As there is limited information in the case provided, the causal association between the Reported events Thyroid eye disease and the suspect drug cannot be excluded. The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
Pain in injection site; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 74-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), dose 1 via an unspecified route of administration on an unspecified date (at the age of 74-Years-old) (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history was not reported. Patient's concomitant medication included blood thinner. On an unspecified date, the patient experienced pain in injection site. Patient wanted to know if he could stop his blood thinner medications before getting the second dose pfizer-biontech covid-19 mRNA vaccine. He mentioned that there was no hematoma, and he experienced no side effect aside from the pain in the injection site. At the time of this report, the outcome of event was unknown.  Follow-up attempts are completed. No further information is expected.
Patient called to report she received the COVID-19 vaccine on 02/07/2021, and now has a fever of 101.4. She has not yet taken Tylenol or Advil. She stated she feels achy and is tired. Nurse reviewed with her comfort measures as well as red flags to call 911. Nurse reviewed will follow up 02/09/2021 to check how she is feeling.
When he gave the injection, I felt pretty typical.  It did feel a little thicker, like an odd pressure, but not alarming.  I get flu shots every year, so I know how they should feel.  About 20 minutes later, I felt some heat in my injection arm and hand.  Not an all over general warmth, but felt like my vein in my arm and hand were stinging and burning.  Lasted about 5 minutes.  Then the typical sore muscle feeling started the next day.  Again, normal stuff.  Now, it is 13 days later, and in STILL have enough pain in my arm where I can't raise it over my head easily.  I am not able to do what I need to do for regular daily things without pain.  Usually, this pain lasts 3-4 days.  NEVER has taken this long to heal.  What can I do to relieve this pain.
Child received vaccines 07/01/2003, onset of symptoms 07/02/2003, return to clinic 07/03/2003-noted swelling from right deltoid to right elbow with moderate degree of erythema.  From extremities right mid upper extremity malpures 21 cm diameter vs 170m of left mid upper extremity.  Area warm to touch.  Denies pain.
Pt developed a red, warm, swollen area around the injection site approximately 2 inches wide and 6 inches long. Arm is extremely sore.
Information has been received from an RN concerning a 69 year old patient who in November or December 2007 was vaccinated IM with a dose of pneumococcal 23v polysaccharide vaccine, lot #657626/1084U. The patient commented that the injection was painful and 1-2 days later developed warmth and localized hives at the injection site. The patient also reported pain from the shoulder to the breast area. Medical attention was sought. The patient was recovering. The nurse indicated that 2 additional patients had identical adverse experiences from pneumococcal 23v polysaccharide vaccine, lot #1084U, and requested a lot check to ensure the product was safe to use. A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
Started with numbness in left and/or right index, middle and ring fingers when sleeping for first two to three weeks. Then over a span of eight weeks with continuous numbness and tingly like when leg falls a sleep including , neuropathy pain in fingers  waking me up between the hours of 1:30 -2:30 am daily requiring walking and shaking arms and fingers till pain subsided so I could return to sleep. Extreme loss of hand and finger strength upon waking up each morning, most mornings cannot hold a tooth brush to brush teeth.  Reported to primary and primary provided a referral for Neurologist. Saw Neurologist in late June had a follow-up for testing for carpal tunnel.  Have never had any symptoms for carpal prior to second shot.  Recommended wrist splints when sleeping have been wearing every night and symptoms diminished for approximately 4 weeks and have now begun to reappear even while wearing splints and  now accompanied with constant stiff neck  and occasional  numbness  index and middle toe on left foot, with swelling in hands and left foot in mornings.
Pt recvd vax 20OCT92 & w/in 30 minutes of receiving vax pt felt that ears plugged up; also exp dizziness & mild vertigo;
The following day, around 11:30 AM after receiving the J & J inoculation, I experienced ringing in my left ear.  It has not subsided.  Today is March 12, Friday and I am writing this at 9:52 AM
Received flu shot for the first time (not quite sure which flu shot it was as I threw away my slip). Two days after broke out into rashes all over my abdomen, back, chest, and neck. Rashes vary in size and shape and are extremely itchy. Seem to flare up through out the day.
Headache, Myalgia, Fever, NauseaVomiting, LIGHTHEADEDNESS, FLUSHING, INJECTION SITE PAIN Narrative:  GOT TESTED FOR COVID  Other Relevant History:
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date, the patients were vaccinated with an unspecified number of doses of VARIVAX (Merck) (lot number, expiry date unknown) that were improperly stored for many years and no adverse events were reported. This is one of the two reports received from the same reporter. Additional information has been requested.
Daily headache, fatigue, nausea, lower back pain, feverish. I am feeling worse now than I did a few days after the shot.
in March/April 2021, Due to continued breathing issues with breathing, my PCM referred me to a Pulmonologist, Dr.   I was placed on a course of Eliquis for 6 months  Again in Jan 2022, i was experiencing heaviness and pain in my chest.  I contacted Dr. to see if it was possible for blood clots to returned.  He stated it low probability but order blood tests to be sure.   over the course of the day, the pain got worse so I went to the ER    Currently on Eliquis, indefinitely.
The day after the vaccine I had a bad migraine with aura (vision loss) lasting for several hours that was atypical for me. I have had migraines with aura before but not like this.
This spontaneous report as received from a physician via an unspecified reporter, refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 09-APR-2014, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 "10 Single dose 0.5mLVls 10SDV" and lot number J011998 with expiration date of 12-FEB-2015 (route of administration was unknown), which was stored at -6.66 Celsius Degrees for 192 hours. The type of excursion was refrigerator and the vaccine status in excursion. No concomitant therapies nor adverse effect were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.